About Durin Life Sciences
Durin Life Sciences is a private company based in Stratford, New Jersey. It has reported $15,200,000 raised in three offerings on Form D since December 2019. Its chief executive is Maribeth Bluyus.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 17, 2023 | Oct 27, 2023amended Jul 21, 2025 | $6,200,000of $10.0M target | 2 | $3.1M | DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Mar 16, 2021 | Mar 23, 2021amended Mar 18, 2025 | $5,499,900fully sold | 3 | $1.8M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Nov 25, 2019 | Dec 19, 2019 | $3,500,100fully sold | 2 | $1.7M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $15,200,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Durin Life Sciences's Form D filed Jul 21, 2025.
Earlier filings also listed Mert Sahin (chief executive officer, last listed Mar 2025) and Benjamin Belinka, Jr. (chief executive officer and president, last listed Dec 2019).